Literature DB >> 11376122

The three dimensional structure of the type I insulin-like growth factor receptor.

C W Ward1, T P Garrett, N M McKern, M Lou, L J Cosgrove, L G Sparrow, M J Frenkel, P A Hoyne, T C Elleman, T E Adams, G O Lovrecz, L J Lawrence, P A Tulloch.   

Abstract

Ever since the discovery of insulin and its role in the regulation of glucose metabolism, there has been great interest in the molecule itself, the insulin-like growth factors (IGFs), and their receptors (IR and IGF-R). These receptors form a subfamily of tyrosine kinase receptors which are large, transmembrane proteins consisting of several structural domains. Their ectodomains have a similar arrangement of two homologous domains (L1 and L2) separated by a Cys rich region. The C-terminal half of their ectodomains consists of three fibronectin type 3 repeats, and an insert domain that contains the alpha-beta cleavage site. This review summarises the key developments in the understanding of the structure of this family of receptors and their relation to other multidomain proteins. Data presented will include multiple sequence analyses, single molecule electron microscope images of the IGF-1R, insulin receptor (IR), and IR-Fab complexes, and the three dimensional structure of the first three domains of the IGF-1R determined to 2.6 A resolution by x ray crystallography. The L domains each adopt a compact shape consisting of a single stranded, right handed beta-helix. The Cys rich region is composed of eight disulphide bonded modules, seven of which form a rod shaped domain with modules associated in an unusual manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11376122      PMCID: PMC1187049          DOI: 10.1136/mp.54.3.125

Source DB:  PubMed          Journal:  Mol Pathol        ISSN: 1366-8714


  53 in total

1.  Congenital insulin resistance associated with a conformational alteration in a conserved beta-sheet in the insulin receptor L1 domain.

Authors:  M Rouard; J Bass; F Grigorescu; T P Garrett; C W Ward; G Lipkind; C Jaffiole; D F Steiner; G I Bell
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

2.  Membrane topology of insulin receptors reconstituted into lipid vesicles.

Authors:  J Tranum-Jensen; K Christiansen; J Carlsen; G Brenzel; J Vinten
Journal:  J Membr Biol       Date:  1994-06       Impact factor: 1.843

3.  Crystal structure of the tenth type III cell adhesion module of human fibronectin.

Authors:  C D Dickinson; B Veerapandian; X P Dai; R C Hamlin; N H Xuong; E Ruoslahti; K R Ely
Journal:  J Mol Biol       Date:  1994-03-04       Impact factor: 5.469

4.  Structural organization of the human insulin receptor ectodomain.

Authors:  E M Schaefer; H P Erickson; M Federwisch; A Wollmer; L Ellis
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

Review 5.  Building proteins with fibronectin type III modules.

Authors:  I D Campbell; C Spitzfaden
Journal:  Structure       Date:  1994-05-15       Impact factor: 5.006

6.  Identification of a disulfide bridge connecting the alpha-subunits of the extracellular domain of the insulin receptor.

Authors:  L Schäffer; L Ljungqvist
Journal:  Biochem Biophys Res Commun       Date:  1992-12-15       Impact factor: 3.575

7.  Identification of determinants that confer ligand specificity on the insulin receptor.

Authors:  A S Andersen; T Kjeldsen; F C Wiberg; H Vissing; L Schäffer; J S Rasmussen; P De Meyts; N P Møller
Journal:  J Biol Chem       Date:  1992-07-05       Impact factor: 5.157

8.  Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation.

Authors:  D W Banner; A D'Arcy; W Janes; R Gentz; H J Schoenfeld; C Broger; H Loetscher; W Lesslauer
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

9.  Cysteine-524 is not the only residue involved in the formation of disulphide-bonded dimers of the insulin receptor.

Authors:  S L Macaulay; M Polites; D R Hewish; C W Ward
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

10.  Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants.

Authors:  R Schumacher; M A Soos; J Schlessinger; D Brandenburg; K Siddle; A Ullrich
Journal:  J Biol Chem       Date:  1993-01-15       Impact factor: 5.157

View more
  15 in total

1.  Insulin receptor-related receptor as an extracellular alkali sensor.

Authors:  Igor E Deyev; Fabien Sohet; Konstantin P Vassilenko; Oxana V Serova; Nadezhda V Popova; Sergey A Zozulya; Elena B Burova; Pascal Houillier; Dmitry I Rzhevsky; Anastasiya A Berchatova; Arkady N Murashev; Anton O Chugunov; Roman G Efremov; Nikolai N Nikol'sky; Eugenio Bertelli; Dominique Eladari; Alexander G Petrenko
Journal:  Cell Metab       Date:  2011-06-08       Impact factor: 27.287

2.  Targeting IGF-IR with ganitumab inhibits tumorigenesis and increases durability of response to androgen-deprivation therapy in VCaP prostate cancer xenografts.

Authors:  Cale D Fahrenholtz; Pedro J Beltran; Kerry L Burnstein
Journal:  Mol Cancer Ther       Date:  2013-01-24       Impact factor: 6.261

Review 3.  Ligand-induced ErbB receptor dimerization.

Authors:  Mark A Lemmon
Journal:  Exp Cell Res       Date:  2008-10-31       Impact factor: 3.905

Review 4.  Anti-EGFR Agents: Current Status, Forecasts and Future Directions.

Authors:  Radoslaw Kwapiszewski; Sebastian D Pawlak; Karolina Adamkiewicz
Journal:  Target Oncol       Date:  2016-12       Impact factor: 4.493

5.  An informatics search for the low-molecular weight chromium-binding peptide.

Authors:  Deendayal Dinakarpandian; Vincent Morrissette; Shveta Chaudhary; Kambiz Amini; Brian Bennett; J David Van Horn
Journal:  BMC Chem Biol       Date:  2004-12-16

6.  Extracellular vimentin interacts with insulin-like growth factor 1 receptor to promote axonal growth.

Authors:  Michiko Shigyo; Tomoharu Kuboyama; Yusuke Sawai; Masahito Tada-Umezaki; Chihiro Tohda
Journal:  Sci Rep       Date:  2015-07-14       Impact factor: 4.379

7.  Mechanisms of activation of receptor tyrosine kinases: monomers or dimers.

Authors:  Ichiro N Maruyama
Journal:  Cells       Date:  2014-04-22       Impact factor: 6.600

8.  BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549.

Authors:  S Elizabeth Franks; Robert A Jones; Ritesh Briah; Payton Murray; Roger A Moorehead
Journal:  BMC Res Notes       Date:  2016-03-01

9.  Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis.

Authors:  Chang Youl Lee; Jeong Hee Jeon; Hyung Jung Kim; Dong Hwan Shin; Tae Woong Roh; Chul Min Ahn; Yoon Soo Chang
Journal:  Korean J Intern Med       Date:  2008-09       Impact factor: 2.884

10.  Membranous Insulin-like Growth Factor-1 Receptor (IGF1R) Expression Is Predictive of Poor Prognosis in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Lung Adenocarcinoma.

Authors:  Eunhyang Park; Soo Young Park; Hyojin Kim; Ping-Li Sun; Yan Jin; Suk Ki Cho; Kwhanmien Kim; Choon-Taek Lee; Jin-Haeng Chung
Journal:  J Pathol Transl Med       Date:  2015-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.